Professional Documents
Culture Documents
P
ressure ulcers are a key quality issue for the NHS. Therapy-bed provision
The published results of the Safety Thermometer The Newcastle upon Tyne Hospitals NHS Foundation
data influences public perception of the quality of Trust is a large tertiary hospital with 98 wards over two
care delivered by each trust. Pressure ulcers represent sites (1750 beds and 100 critical-care beds). Belonging to
a major burden to patients, carers and the healthcare system, the Shelford group of hospitals, it is a regional centre with
affecting approximately one in ten hospital and one in multiple specialties.
twenty community patients (Nixon et al, 2016). They In 2005, the Trust, led by the tissue viability nurse
impact on the physical, social and psychological wellbeing of consultant, adopted a third model to pressure-ulcer
patients. In 2004, Bennet et al reported that pressure ulcers prevention; the non-powered approach. Over 250 gel
cost an estimated £1.4-2.1 billion annually, equivalent to therapy mattresses (RIK Fluid Mattress, ArjoHuntleigh) were
4% of NHS expenditure; 4 years later, Riordan and Voegeli purchased alongside high-quality foam mattresses, with no
(2009) estimated annual costs to be £2.64 billion. The cost change in prevalence. A very small number of low-air-loss
of treating a pressure ulcer in the UK ranges from £1214 to therapy mattresses (TheraKair Visio, ArjoHuntleigh) were
£14 108 per year (Dealey et al, 2012). also used, but overall, the Trust was 98.6% non-powered.
The selection of therapy beds (or surfaces) is just one This quality improvement programme was described in
aspect of preventative care, but the necessity to provide an Pagnamenta (2007).
air-flow mattress for all patients who are at risk of developing
pressure ulcers has been questioned before (Pagnamenta, The Newcastle approach
2007). Evidence to support the use of such products is Preventing pressure ulcers is complex. Strategies for the
limited (Nguyen et al, 2015) and has been recognised by the effective prevention of pressure ulcers are often presented
Government, which is supporting the University of Leeds to as a bundle of care that includes skin care, the appropriate
research this area. The results of a randomised controlled trial selection of surfaces, a strict repositioning regime, the
to compare the effectiveness of high-specification foam and management of incontinence and finally a requirement to
address any nutritional deficits (Whitlock, 2013).
This model is multifaceted and reflects the complexities
Fania Pagnamenta, Nurse Consultant (Tissue Viability), that multiple interventions required for the effective
Newcastle upon Tyne Hospitals NHS Foundation Trust, Fania. prevention of pressure ulcers. Each intervention has been
Pagnamenta@nuth.nhs.uk
thoroughly detailed so that clinicians from other care
Accepted for publication: January 2017 providers may find similarities and possible application of this
model to their setting.
S28 British Journal of Nursing 2017, Vol 26, No 6: TISSUE VIABILITY SUPPLEMENT
Box 1. Plan of care for ‘at risk’ or ‘with existing damage’ the company, this product was further developed. The updated
design no longer includes the membrane in the middle of the
■■ Inspect skin an on admission, transfer and discharge and at every positional mattress so the cover is not subjected to additional forces.
change
■■ Daily Braden Scale
In 2014, the Trust purchased 109 Dyna-Form Static Air HZ
■■ Commence ‘FOCUS’ (intentional rounding) (Direct Healthcare Services Ltd). The following year, a further
■■ Reposition every 2 hours 161 were purchased and in 2016, 149. The failure rate of the
■■ Elevate heels while in bed cover dropped significantly, only 6 covers were replaced; a
■■ Provide pressure-relieving cushion when seated
failure rate of 1.4%, which had been previously deemed to be
■■ Stand every hour when seated
■■ Minimise time spent in chair to 2–3 hours at a time
an acceptable failure rate (Pagnamenta, 2013).
■■ Deliver skin care at every positional change At the time of writing, the Trust holds 492 Dyna-Foam
■■ Offer patient and carer a pressure ulcer prevention leaflet Static Airs, 419 Dynafoam StaticAirs HZ, an estimated
40 remaining RIKs and approximately 800 high-quality foam
Box 2. Data collection mattresses. These are permanently placed on the wards. With
intentional rounding, patients are asked ‘How comfortable
■■ Safety Thermometer: the worst ulcer is reported as a new ‘harm’ (trust-acquired) are you on this therapy mattress?’ and their answer forms part
or old ‘harm’ (non-trust acquired) on one finite day of the month (true prevalence
data). Safety Thermometer data are collected on a monthly basis
of the decision as to which non-powered product is selected.
■■ DATIX is the method by which staff report any category of ulcers. Moisture lesions The tissue viability team in the Trust believes that the main
are also reported. The report highlights whether these ulcers are trust acquired role of therapy mattresses is to provide comfort to patients
or non-trust acquired. These reports are the most accurate and useful to analyse. and to ensure rest and sleep is obtained while in the Trust’s
The trend since January 2013 is a general reduction care. The objective is to allow patients more energy for self-
repositioning and/or to assist health professionals with their
Skin care programme of repositioning (Pagnamenta, 2009).
Skin care described by Rees and Pagnamenta (2009) offers The Trust continues to hold between 20 and 25 low-
a simple message (products listed are part of Trust guidance): air-loss mattresses for patients who require a higher product
wash all skin with an emollient (Hydromol, Alliance specification, namely burns patients, plastic surgery patients
Pharmaceuticals Ltd), mixed in warm water, use a barrier and very thin, cachexic patients. At times, the non-powered
spray (Medi Derma-S spray, Medicareplus International Ltd) products may not provide sufficient comfort. These low-
for prevention or use a dimethicone-based skin protectant air-loss mattresses are held in the equipment library and are
(Proshield, H&R Healthcare) if the skin is broken. accessed through the tissue viability service via an online
request system. The 98.5% non-powered approach described
Therapy mattresses in Pagnamenta (2007) has been sustained over the last 10 years.
In 2012, the Trust adopted a zero-tolerance policy to pressure
ulcers. A task force group was established and the first task was Repositioning
to audit existing stock of non-powered therapy mattresses. It Risk assessment is undertaken using the Braden Scale
was established that the RIK mattresses were deteriorating for Predicting Pressure Ulcer Risk. Braden is a pressure
and it was no longer cost effective to replace them. The Trust ulcer scoring tool that aids clinicians with pressure ulcer
looked for another product that was manufactured in the UK prevention (Pancorbo-Hidalgo et al, 2006). The risk is
that would replace the RIK. assessed on admission and then daily for all patients at risk
In 2012, the Trust purchased 419 Dyna-Form Static Air (Braden <17). The plan of care that is expected for patients
mattress replacement systems (Direct Healthcare Services Ltd); who are at risk is detailed in Box 2.
they combine the benefits of air displacement with high-
quality foam. Incorporating air and foam with a valves system Management of incontinence
allows the pressures to readjust under the patient’s body weight Flat underpads have been removed from all clinical areas as
and movement. All component parts are interchangeable and in the Trust. Clinical experience suggests that these products
replaceable, maximising product life. may contribute to the development of pressure damage. The
In the Trust, mattress audits had been undertaken yearly recommendation to only use body-worn absorbent pads
until 2009 when these audits were increased to four times with a pant system after a thorough continence assessment
per year. These audits involve a thorough check of the cover has also been part of the programme. Bowel management
and the patency of the foam to ensure they remain fit for systems have also been introduced, first within critical care
purpose. As old foam mattress failed, they were replaced with and, with support, in other clinical areas, described in Rees
Static Air mattresses. and Sharpe (2009).
While this mattress provided good pressure ulcer
redistribution, within 2 years, 107 covers needed replacing Nutrition
(failure rate of 4.6% over 2 years). The rationale for the high All patients are screened using the Malunitrition Universal
rate of cover failure appeared to be due to the membrane that Screening Tool (MUST) (Neelemaat et al, 2011) and referred
covered the foam in the middle of the mattress; under pressure, to dietetics if appropriate. Furthermore, all patients with
for example when using moving and handling equipment to existing deep pressure ulcers are also referred. Currently,
move patients from bed to trolley, this would balloon and cause there is not the resource in the tissue viability department
the cover to stretch and tear. After feedback was provided to to provide dietetic input to patients at risk of developing
S30 British Journal of Nursing 2017, Vol 26, No 6: TISSUE VIABILITY SUPPLEMENT
140
pressure ulcers who do not score on the MUST or who have
developed superficial skin damage.
120
Monitoring
100 The prevalence of pressure ulcers is measured using two data
collection tools: Safety Thermometer (Power et al, 2012) and
80 through DATIX Software (See Box 2).
Reporting pressure ulcers varies in each establishment
60 (Tissue Viability Society, 2013). In order to provide a full
picture of the Trust’s model, it specifies that:
40 ■■ Pressure ulcers are hospital acquired if they are present on
admission. In line with currently recommendations (Tissue
20 Viability Society, 2012), the 72 hour rule is not used
■■ Pressure damage caused by medical devices is reported but
0
not included in the pressure ulcer data
Mar 13
May 13
Jul 13
Sep 13
Nov 13
Jan 14
Mar 14
May 14
Jul 14
Sep 14
Nov 14
Jan 15
Mar 15
May 15
Jul 15
Sep 15
Nov 15
Jan 16
Mar 16
May 16
Jul 16
Sep 16
Nov 16
Jan 17
Jan 13
0
Discussion and conclusion
The Newcastle upon Tyne Hospitals NHS Foundation
Jan 13
Mar 13
May 13
Jul 13
Sep 13
Nov 13
Jan 14
Mar 14
May 14
Jul 14
Sep 14
Nov 14
Jan 15
Mar 15
May 15
Jul 15
Sep 15
Nov 15
Jan 16
Mar 16
May 16
Jul 16
Sep 16
Nov 16
S32 British Journal of Nursing 2017, Vol 26, No 6: TISSUE VIABILITY SUPPLEMENT
PRESSURE ULCERS
n
infection prevention, control and management in any health care setting.
management in any health care setting.
The book will be an invaluable tool
to help staff reduce avoidable health
infections. It provides healthcare practitione care associated
rs with a basic understanding of infectious
and Control
agents, their physiology, classications
and transmission. It also covers the
management of infections, presenting clinical
The book will be an invaluable tool to help staff reduce avoidable health care measures as well as useful tips and
best practice guidelines and precaution
tools to safeguard patients from infections.
addition, it presents the practical considerat
ary
In
ions for the management and treatment
associated infections. It provides healthcare practitioners with a basic understanding
infections, such as staff roles and responsibi
management of invasive devices and
lities, environmental hygiene, sterilizatio
of
n,
Edited by Vinice Thomas
much more.
of infectious agents, their physiology, classifications and transmission. It also covers
The content is designed be clear, concise
features learning outcomes, checklists,
and highly practical. The user-friend
ly format
tables, bullet points and practical examples
the clinical management of infections, presenting best practice guidelines andthroughout. Chapters include relevant
discussion questions to aid learning.
case studies, reective practice activities
and
precautionary measures as well as useful tips and tools to safeguard patients from
About the editor
infections. In addition, it presents the practical
Vinice Thomasconsiderations for
is Assistant Director of Nursing/Clinical
the management and
Governance at Harrow Primary
Care Trust and acted in the role of Director
treatment of infections, such as staff rolesEngland’s
and
the Infection responsibilities, environmental
of Infection Prevention and Control,
Control Team. She had worked within
the Chief Nursing Officer for
managing hygiene,
Directorate as part of the HCAI and
sterilization, management of invasive devices and much more.
responsible for supporting NHS Trusts
control processes.
Cleanliness division as a Portfolio Manager
across the country to strengthen their
infection
throughout. Chapters include relevant case studies, reflective practice activities and
Conditions
Edited by Vinice Thomas
ISBN-13: 978-1-85642-415-8; 234 x 156 mm; paperback; 250 pages; publication 2010; £24.99
9 781856 424158
British Journal of Nursing 2017, Vol 26, No 6: TISSUE VIABILITY SUPPLEMENT S33
Copyright of British Journal of Nursing is the property of Mark Allen Publishing Ltd and its
content may not be copied or emailed to multiple sites or posted to a listserv without the
copyright holder's express written permission. However, users may print, download, or email
articles for individual use.